Agilent Technologies Inc. has announced that its secure online custom microarray design tool now includes probe design capability. The eArray v4.5 is designed to enable scientists to harness the ...

Agilent Technologies Inc and Paradigm Genetics Inc announced the commercial availability of an Arabidopsis microarray kit featuring more than 14,800 plant gene sequences derived from public domain ...

Agilent Technologies Inc. and Oxford Gene Technology (OGT) announced they have expanded an existing partnership into an exclusive agreement for Agilent to provide OGT with oligonucleotide microarrays ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification ...

Harnessing the strengths of Agilent’s microarray technology and OBD’s 3D genomic recognition algorithms, the EpiSwitch® Explorer Array Kit provides results at a high throughput, with high resolution ...

The State of the Microarray | Selected Suppliers of Microarray Chips, Spotters, and Readers Courtesy of Amersham Biosciences Note: a = arrays; r = reader; s = spotter Affymetrix www.affymetrix.com - a ...

Wilmington, Delaware, United States, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global microarray scanners market is estimated to flourish at a CAGR of 7.5% from 2023 to ...

OXFORD - Agilent Technologies (NYSE:A) and Oxford BioDynamics (AIM:OBD) will jointly present their collaborative 3D genomics platform in a GenomeWeb webinar scheduled for Thursday evening, according ...

OXFORD, England--(BUSINESS WIRE)-- Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for personalized healthcare based on the EpiSwitch® 3D ...